Journal of drugs in dermatology : JDD · 2025
Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mendez Hannah, Vattigunta Mounika, Beer Jacob
Аннотация
INTRODUCTION: Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is a rare chronic condition, with treatments focusing on managing disease symptoms.
CASE PRESENTATION: We present a case of a 72-year-old female with refractory HHD. Despite management with standard HHD treatments, such as antibiotics and corticosteroids, the patient's flares persisted. She was started on ruxolitinib 1.5% cream, with improved symptoms.
DISCUSSION: This case demonstrates the difficulties a patient with refractory HHD may experience, and the significance of exploring novel treatment options to improve disease response and patient quality of life.
CONCLUSION: Ruxolitinib may be an effective treatment option for HHD management, but further investigation is necessary.
CASE PRESENTATION: We present a case of a 72-year-old female with refractory HHD. Despite management with standard HHD treatments, such as antibiotics and corticosteroids, the patient's flares persisted. She was started on ruxolitinib 1.5% cream, with improved symptoms.
DISCUSSION: This case demonstrates the difficulties a patient with refractory HHD may experience, and the significance of exploring novel treatment options to improve disease response and patient quality of life.
CONCLUSION: Ruxolitinib may be an effective treatment option for HHD management, but further investigation is necessary.